Showing results (401-410 of 548) with videos related to
Sort By:
Pageof 55
Journal of the American Chemical Society|August 22, 2017
Mg-Ion Battery Electrode: An Organic Solid's Herringbone Structure Squeezed upon Mg-Ion InsertionIsmael A Rodríguez-Pérez, Yifei Yuan, Clement Bommier, et al.Molecular Medicine (Cambridge, Mass.)|May 5, 2015
Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry DiseaseKaren M Ashe, Eva Budman, Dinesh S Bangari, et al.Blood|December 15, 2007
A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignanciesNancy L Bartlett, Anas Younes, Matthew H Carabasi, et al.The New England Journal of Medicine|November 5, 2015
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell LymphomaJia Ruan, Peter Martin, Bijal Shah, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2016
CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher DiseaseJohn Marshall, Ying Sun, Dinesh S Bangari, et al.Human Molecular Genetics|May 8, 2012
Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney diseaseThomas A Natoli, Hervé Husson, Kelly A Rogers, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2019
Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase ActivityJohn Marshall, Jennifer B Nietupski, Hyejung Park, et al.Leukemia & Lymphoma|April 10, 2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphomaSarah C Rutherford, Biree Andemariam, Shibu M Philips, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphomaJohn P Leonard, Brian K Link, Christos Emmanouilides, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40LMontserrat Cols, Carolina M Barra, Bing He, et al.Pageof 55